Parallax Volatility Advisers, L.P. Lexicon Pharmaceuticals, Inc. Call Options Transaction History

Parallax Volatility Advisers, L.P.

  • $53.5 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2021

Feb 14, 2022
BUY
$3.81 - $6.16 $7,620 - $12,320
2,000 New
2,000 $8,000
Q3 2021

Nov 15, 2021
SELL
$3.38 - $5.35 $32,786 - $51,895
-9,700 Closed
0 $0
Q2 2021

Aug 16, 2021
SELL
$4.12 - $5.87 $114,536 - $163,186
-27,800 Reduced 74.13%
9,700 $44,000
Q2 2018

Aug 14, 2018
BUY
$7.8 - $13.69 $292,500 - $513,375
37,500 New
37,500 $450,000

Others Institutions Holding LXRX

# of Institutions
137
Shares Held
238M
Call Options Held
459K
Put Options Held
133K
View Full List

About LEXICON PHARMACEUTICALS, INC.

LXRX Quotes by TradingView
  • Ticker LXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 188,726,000
  • Market Cap $143M
  • Description
  • Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...
More about LXRX
Track This Portfolio

Track Parallax Volatility Advisers, L.P. Portfolio

Follow Parallax Volatility Advisers, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email